Clinical Trial Update: Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating vancomycin prophylaxis to prevent recurrent Clostridioides difficile infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Corewell Health West | Conditions: Clostridium Difficile Infection | Phase 4 | Status: UNKNOWN